drugset / Trial / NCT04180761

Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer

NCT04180761 ↗

Phase 2 Withdrawn University Hospital Tuebingen
NaSingle-groupOpen-labelTreatment

Summary

This study investigates the effect of a combined therapy with gastrectomy and HIPEC in localized advanced gastric cancer.

Timeline

Start
2019-11
Primary completion
2022-03
Completion
2022-09

Outcome

Outcome not reported

Stopped (Enrollment): “No partecipants Enrolled”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 15 mg/m2 Intravenous
Subject Doxorubicin Other / unclassified 75 mg/m2 Intravenous

Indications